Jech R - Search Results

1

CHD8-related disorders redefined: an expanding spectrum of dystonic phenotypes.

Sorrentino U, Boesch S, Doummar D, Ravelli C, Serranova T, Indelicato E, Winkelmann J, Burglen L, Jech R, Zech M. Sorrentino U, et al. Among authors: jech r. J Neurol. 2024 May;271(5):2859-2865. doi: 10.1007/s00415-024-12271-x. Epub 2024 Mar 5. J Neurol. 2024. PMID: 38441608 Free PMC article.

2

Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.

Colosimo C, Charles D, Misra VP, Maisonobe P, Om S; INTEREST IN CD2 study group. Colosimo C, et al. J Neurol. 2019 Dec;266(12):3047. doi: 10.1007/s00415-019-09549-w. J Neurol. 2019. PMID: 31595379 Free PMC article.

3

How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.

Colosimo C, Charles D, Misra VP, Maisonobe P, Om S; INTEREST IN CD2 study group. Colosimo C, et al. J Neurol. 2019 Dec;266(12):3038-3046. doi: 10.1007/s00415-019-09527-2. Epub 2019 Sep 9. J Neurol. 2019. PMID: 31501975 Free PMC article.

4

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.

Misra VP, Colosimo C, Charles D, Chung TM, Maisonobe P, Om S; INTEREST IN CD2 study group. Misra VP, et al. J Neurol. 2018 Feb;265(2):402-409. doi: 10.1007/s00415-017-8698-2. Epub 2017 Dec 21. J Neurol. 2018. PMID: 29270685 Free PMC article.

5

Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.

Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Gracies JM, et al. Among authors: jech r. Lancet Neurol. 2015 Oct;14(10):992-1001. doi: 10.1016/S1474-4422(15)00216-1. Epub 2015 Aug 26. Lancet Neurol. 2015. PMID: 26318836 Clinical Trial.

6

Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.

Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group. Trenkwalder C, et al. Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19. Lancet Neurol. 2015. PMID: 26494524 Clinical Trial.

7

Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.

Comella CL, Jankovic J, Hauser RA, Patel AT, Banach MD, Ehler E, Vitarella D, Rubio RG, Gross TM; ASPEN-1 Study Group. Comella CL, et al. Neurology. 2024 Feb 27;102(4):e208091. doi: 10.1212/WNL.0000000000208091. Epub 2024 Jan 31. Neurology. 2024. PMID: 38295339 Free PMC article. Clinical Trial.

8

Mixed anxiety-depressive disorder in Parkinson's disease associated with worse resting state functional response to deep brain stimulation of subthalamic nucleus.

Filip P, Lasica A, Uhrová T, Mana J, Růžička F, Keller J, Mueller K, Burdová K, Kiakou D, Jech R. Filip P, et al. Among authors: jech r. Heliyon. 2024 May 6;10(10):e30698. doi: 10.1016/j.heliyon.2024.e30698. eCollection 2024 May 30. Heliyon. 2024. PMID: 38778942 Free PMC article.

9

Dystonia and mitochondrial disease: the movement disorder connection revisited in 900 genetically diagnosed patients.

Indelicato E, Schlieben LD, Stenton SL, Boesch S, Skorvanek M, Necpal J, Jech R, Winkelmann J, Prokisch H, Zech M. Indelicato E, et al. Among authors: jech r. J Neurol. 2024 May 22. doi: 10.1007/s00415-024-12447-5. Online ahead of print. J Neurol. 2024. PMID: 38775934 No abstract available.

10

Structural and microstructural predictors of cognitive decline in deep brain stimulation of subthalamic nucleus in Parkinson's disease.

Filip P, Mana J, Lasica A, Keller J, Urgošík D, May J, Mueller K, Jech R, Bezdicek O, Růžička F. Filip P, et al. Among authors: jech r. Neuroimage Clin. 2024 May 8;42:103617. doi: 10.1016/j.nicl.2024.103617. Online ahead of print. Neuroimage Clin. 2024. PMID: 38749145 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page